Delivery Order SPE2DR25D9113-SPE2DR26FCHU3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, was not set aside for any particular business category. DMS Pharmaceutical Group will perform under this order from...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the vendor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $49,586.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through full and open competition. The contract is funded by the...
- The Defense Logistics Agency awarded a $12,364.81 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The award, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, carries no set-aside designation and utilizes firm fixed-price pricing. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $24,493.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and was awarded on November 18, 2025. This award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The Defense Logistics Agency issued a delivery order valued at $24,677 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 20 mg. The award, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, utilized firm fixed-price pricing with no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in an unrestricted procurement environment. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $37,495.66 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 10 mg on December 2, 2025, with an ultimate completion date of December 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The delivery order is to be fulfilled at the contractor's location in Park...
- The Defense Logistics Agency has awarded a $33,240.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The delivery order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60 count). This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, was awarded without a set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,400.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count packages). This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in...
- SPE2DR25D9113Indefinite Delivery Contract
- SPE2DR25D9113-SPE2DR26FCHU3Delivery Order
The Defense Logistics Agency issued a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 20 mg, a firm fixed-price pharmaceutical procurement with an ultimate completion date of December 10, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received this award without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order was funded by the Defense Logistics Agency and will be performed at the contractor's location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, designated contract SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, and includes a 30-month base period with three 30-month option periods. Through this vehicle, DMS Pharmaceutical Group serves as a critical regional prime vendor contractor supplying a comprehensive range of pharmaceuticals—including branded and generic prescription drugs, biologics, vaccines, and medical consumables—to support recurring medical supply needs of military healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 12/8/25 |